Innovative Eyewear, Inc. Announces Exercise of Warrants
Innovative Eyewear, Inc. (Nasdaq: LUCY), a smart eyewear developer, has announced agreements for the immediate exercise of certain outstanding warrants. 126,699 shares of common stock, originally issued on June 26, 2023, with an initial exercise price of $21.00 per share, will now be exercised at a reduced price of $5.00 per share. The transaction is expected to close around September 4, 2024, generating gross proceeds of approximately $633,495 for the company.
In exchange, Innovative Eyewear will issue new unregistered Series A and Series B warrants, each for up to 126,699 shares, with an exercise price of $5.00 per share. The Series A warrants will expire in 5.5 years, while the Series B warrants will expire in 18 months. The company plans to use the net proceeds for working capital and general corporate purposes.
Innovative Eyewear, Inc. (Nasdaq: LUCY), sviluppatore di occhiali intelligenti, ha annunciato accordi per l'esercizio immediato di alcuni warrant in circolazione. 126.699 azioni ordinarie, emesse inizialmente il 26 giugno 2023, con un prezzo di esercizio iniziale di $21,00 per azione, saranno ora esercitate a un prezzo ridotto di $5,00 per azione. Si prevede che la transazione si chiuda intorno al 4 settembre 2024, generando proventi lordi di circa $633.495 per l'azienda.
In cambio, Innovative Eyewear emetterà nuovi warrant di Serie A e Serie B non registrati, ciascuno per un massimo di 126.699 azioni, con un prezzo di esercizio di $5,00 per azione. I warrant di Serie A scadranno in 5,5 anni, mentre i warrant di Serie B scadranno in 18 mesi. L'azienda prevede di utilizzare i proventi netti per il capitale circolante e fini aziendali generali.
Innovative Eyewear, Inc. (Nasdaq: LUCY), desarrollador de gafas inteligentes, ha anunciado acuerdos para el ejercicio inmediato de ciertos warrants en circulación. 126.699 acciones ordinarias, emitidas originalmente el 26 de junio de 2023, con un precio de ejercicio inicial de $21.00 por acción, se ejercerán ahora a un precio reducido de $5.00 por acción. Se espera que la transacción se cierre alrededor del 4 de septiembre de 2024, generando ingresos brutos de aproximadamente $633,495 para la empresa.
A cambio, Innovative Eyewear emitirá nuevos warrants no registrados de Serie A y Serie B, cada uno por hasta 126.699 acciones, con un precio de ejercicio de $5.00 por acción. Los warrants de Serie A vencerán en 5,5 años, mientras que los warrants de Serie B vencerán en 18 meses. La empresa planea utilizar los ingresos netos para capital de trabajo y fines corporativos generales.
Innovative Eyewear, Inc. (Nasdaq: LUCY) 는 스마트 안경 개발업체로서, 특정 미결제 워런트의 즉각적인 행사에 대한 계약을 발표했습니다. 126,699주의 보통주가 2023년 6월 26일에 최초 발행되었으며, 초기 행사 가격은 주당 $21.00이었지만, 이제 주당 $5.00로 행사됩니다. 이 거래는 2024년 9월 4일 경에 마무리될 것으로 예상되며, 회사에 약 $633,495의 총 수익을 창출할 것입니다.
대신 Innovative Eyewear는 각각 126,699주까지의 새롭고 등록되지 않은 A시리즈와 B시리즈 워런트를 발행할 예정이며, 행사 가격은 주당 $5.00입니다. A시리즈 워런트는 5.5년 후 만료되며, B시리즈 워런트는 18개월 후 만료됩니다. 회사는 순수익을 운영 자본 및 일반 기업 목적으로 사용할 계획입니다.
Innovative Eyewear, Inc. (Nasdaq: LUCY), un développeur de lunettes intelligentes, a annoncé des accords pour l'exercice immédiat de certains warrants en circulation. 126 699 actions ordinaires, émises à l'origine le 26 juin 2023, avec un prix d'exercice initial de 21,00 $ par action, seront désormais exercées à un prix réduit de 5,00 $ par action. La transaction devrait être clôturée aux alentours du 4 septembre 2024, générant des recettes brutes d'environ 633 495 $ pour l'entreprise.
En échange, Innovative Eyewear émettra de nouveaux warrants de Série A et de Série B non enregistrés, chacun portant sur jusqu'à 126 699 actions, avec un prix d'exercice de 5,00 $ par action. Les warrants de Série A expireront dans 5,5 ans, tandis que les warrants de Série B expireront dans 18 mois. L'entreprise prévoit d'utiliser les produits nets pour le fonds de roulement et des fins corporatives générales.
Innovative Eyewear, Inc. (Nasdaq: LUCY), ein Entwickler von intelligenter Brillen, hat Vereinbarungen zum sofortigen Ausüben bestimmter ausgegebener Warrants bekannt gegeben. 126.699 Aktien des Stammkapitals, ursprünglich am 26. Juni 2023 ausgegeben und mit einem ursprünglichen Ausübungspreis von $21,00 pro Aktie, werden jetzt zu einem reduzierten Preis von $5,00 pro Aktie ausgeübt. Die Transaktion wird voraussichtlich um den 4. September 2024 abgeschlossen, wodurch brutto Einnahmen von etwa $633.495 für das Unternehmen erzielt werden.
Im Gegenzug wird Innovative Eyewear neue unregistrierte Series A und Series B Warrants ausgeben, jeweils für bis zu 126.699 Aktien, mit einem Ausübungspreis von $5,00 pro Aktie. Die Series A Warrants laufen in 5,5 Jahren ab, während die Series B Warrants in 18 Monaten ablaufen. Das Unternehmen plant, die Nettomittel für Betriebskapital und allgemeine Unternehmenszwecke zu verwenden.
- Immediate influx of approximately $633,495 in gross proceeds
- Reduced warrant exercise price from $21.00 to $5.00 per share, potentially attracting more investors
- Issuance of new Series A and Series B warrants, providing potential for future capital
- Dilution of existing shareholders' ownership due to the issuance of 126,699 new shares
- Reduction in warrant exercise price from $21.00 to $5.00 indicates potential undervaluation of the stock
- Additional dilution potential from new Series A and Series B warrants if exercised
Insights
This warrant exercise transaction is a mixed bag for Innovative Eyewear. On the positive side, it provides an immediate
The reduced exercise price of
The issuance of new Series A and B warrants could lead to further dilution if exercised. This complex financial maneuver might be seen as a short-term fix that could have long-term consequences for shareholder value. Investors should closely monitor the company's cash burn rate and future capital needs.
The transaction's structure raises some regulatory considerations. The new warrants are being offered in a private placement, exempt from SEC registration requirements. This approach allows for faster execution but limits the potential investor base.
The company's commitment to file a registration statement within 30 days for the resale of shares issuable upon exercise of the new warrants is a positive step for transparency. However, investors should be aware that until this registration is effective, these securities will have liquidity.
The disclaimer about not constituting an offer to sell is a standard legal safeguard. It's important for ensuring compliance with securities laws and protecting the company from potential legal issues related to unregistered offerings. Overall, the legal structure appears designed to balance speed of capital raising with regulatory compliance.
This warrant exercise reflects broader challenges in the smart eyewear market. Despite partnerships with well-known brands like Nautica, Eddie Bauer and Reebok, Innovative Eyewear seems to be struggling to gain traction. The need for this financing suggests that product adoption or revenue growth may be slower than anticipated.
The reduced warrant price could indicate market skepticism about the company's prospects or the overall smart eyewear sector. It's worth noting that major tech players have also faced difficulties in this space. Investors should consider whether Innovative Eyewear has a unique value proposition that can overcome these industry-wide challenges.
The immediate cash infusion might help the company address short-term needs, but long-term success will depend on product-market fit and scalable sales strategies. Keep an eye on upcoming financial reports to gauge progress in revenue growth and market penetration.
H.C. Wainwright & Co. is acting as the exclusive placement agent for the offering.
The shares of common stock issuable upon exercise of the warrants are registered pursuant to an effective registration statement on Form S-1 (File No. 333-272737).
The gross proceeds to the Company from the exercise of the warrants are expected to be approximately
In consideration for the immediate exercise of the warrants for cash, the Company will issue new unregistered Series A warrants to purchase up to an aggregate of 126,699 shares of common stock and new unregistered Series B warrants to purchase up to an aggregate of 126,699 shares of common stock. The new Series A and Series B warrants will have an exercise price of
The new warrants described above are being offered in a private placement and, along with the shares of common stock issuable upon exercise of the new warrants, have not been registered under the Securities Act of 1933, as amended (the "1933 Act"), or applicable state securities laws. Accordingly, the new warrants and shares of common stock issuable upon the exercise of the new warrants may not be offered or sold in
This press release shall not constitute an offer to sell or a solicitation of an offer to buy any of the securities described herein, nor shall there be any sale of these securities in any state or other jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such state or other jurisdiction.
About Innovative Eyewear, Inc.
Innovative Eyewear is a developer of cutting-edge ChatGPT enabled smart eyewear, under the Lucyd®, Nautica®, Eddie Bauer® and Reebok® brands. True to our mission to Upgrade Your Eyewear®, our Bluetooth audio glasses allow users to stay safely and ergonomically connected to their digital lives and are offered in hundreds of frame and lens combinations to meet the needs of the optical market. To learn more and explore our continuously evolving collection of smart eyewear, please visit www.lucyd.co.
Forward Looking Statements
This press release contains certain forward-looking statements, including but not limited to, those relating to the satisfaction of customary closing conditions, the intended use of proceeds from the offering, the anticipated closing of the offering and the planned launch of the Company's new product lines. Forward-looking statements are based on the Company's current expectations and assumptions. The Private Securities Litigation Reform Act of 1995 provides a safe-harbor for forward-looking statements. These statements may be identified by the use of forward-looking expressions, including, but not limited to, "anticipate," "believe," "continue," "estimate," "expect," "future," "intend," "may," "outlook," "plan," "potential," "predict," "project," "should," "will," "would" and similar expressions that predict or indicate future events or trends or that are not statements of historical matters, but the absence of these words does not mean that a statement is not forward-looking. The Company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise, except as required by law. Important factors that could cause actual results to differ materially from those in the forward-looking statements include, among others, market and other conditions, and other factors and risks identified from time to time in the Company's filings with the SEC, including its annual report on Form 10-K under the caption "Risk Factors" filed with the SEC on March 25, 2024.
Investor Relations Contacts:
Innovative Eyewear, Inc.
Scott Powell
Skyline Corporate Communications Group, LLC
Office: +1 (646) 893-5835
Email: scott@skylineccg.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/innovative-eyewear-inc-announces-exercise-of-warrants-302236683.html
SOURCE Innovative Eyewear, Inc.
FAQ
What is the new exercise price for Innovative Eyewear's (LUCY) warrants?
How many shares of Innovative Eyewear (LUCY) are being issued through the warrant exercise?
What are the expected gross proceeds for Innovative Eyewear (LUCY) from this warrant exercise?